Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List
- Saturday, November 14, 2026, 2:11
- Business
- Add a comment
PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 /PRNewswire/ — Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology,…
About the Author
adminasapcorp has written 42626 stories on this site.